6 assets in Pilocytic Astrocytoma

Therapeutic assets addressing Pilocytic Astrocytoma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Dabrafenib Pilocytic Astrocytoma	Novartis Pharmaceuticals	P4	BB (65)
Trametinib Pilocytic Astrocytoma	Novartis Pharmaceuticals	P4	BB (65)
Tovorafenib Pilocytic Astrocytoma	Day One Biopharmaceuticals, Inc.	P2	CC (47)
Cyclophosphamide Pilocytic Astrocytoma	Dana-Farber Cancer Institute	P1	CC (43)
Onc 206 Pilocytic Astrocytoma	Jazz Pharmaceuticals	P1	CC (43)
Rqnestin Pilocytic Astrocytoma	Dana-Farber Cancer Institute	P1	CC (43)